Table 10.
Male |
Female |
||||||||
---|---|---|---|---|---|---|---|---|---|
Group 1, Control |
Group 2, 100 mg/kg/day |
Group 3, 300 mg/kg/day |
Group 4, 1000 mg/kg/day |
Group 1, Control |
Group 2, 100 mg/kg/day |
Group 3, 300 mg/kg/day |
Group 4, 1000 mg/kg/day |
||
Number of animals | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Gland, thyroid | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Heart | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Kidney | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Large intestine, cecum | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Large intestine, colon | Examined | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Large intestine, rectum | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Larynx | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Liver | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 7 | 10 | 10 | 10 | 10 | 10 | |
Prominent lobular architecture | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | |
Abnormal appearance | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |